Human Primary Diabetic Gallbladder Smooth Muscle Cells
BVXDS004
Certified
QualityGlobal
ShippingSupport
24/7Info
IncludedProduct Details
Size
1ml
Product Code
BVXDS004
Quick Specifications
- Product Type: Human Type II Diabetes Endothelial Cells
- Viability: >95% viable (Trypan Blue exclusion)
- Storage: Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
- Shelf Life: Very stable in the Liquid Nitrogen Vapor Phase
- Catalog: BVXDS004
- Growth: Primary cells capable of multiple passages when using recommended medium and proper handling
Human Primary Diabetic Gallbladder Smooth Muscle Cells
Product Description
Characterization Markers Characterized by positive expression of smooth muscle cell-specific. alpha-actin .
Key Features & Benefits
Catalog Number: BVXDS004 Product Format: Frozen Vial Cell Number: > 5x10[5] cells/vial Passage:1(P1) Storage: Liquid Nitrogen, Vapor Phase Intended Use: Research use only (RUO)
Quick Facts
Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Storage
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Applications
Technical Specifications
| Product Type | Human Type II Diabetes Endothelial Cells |
|---|---|
| Viability | >95% viable (Trypan Blue exclusion) |
| Proliferative Capability | Primary cells capable of multiple passages when using recommended medium and proper handling |
| Storage Conditions | Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C). |
| Shelf Life | Very stable in the Liquid Nitrogen Vapor Phase |
| Product Code | BVXDS004 |
| Size/Format | 1ml |
| Category | Primary Cells |
Primary Applications
Applications & Use Cases
Primary Applications
Diabetic Gastroenteropathy: Studying how chronic hyperglycemia leads to motility disorders in the biliary tract. Pharmacodynamics (PD): Testing new drugs (prokinetic agents) designed to restore contraction in the diabetic gallbladder. Mechanotransduction: Studying how the physical stiffness of the diabetic environment affects cell signaling (YAP/TAZ pathways). Inflammation (Lipotoxicity): Investigating how high glucose combined with high lipids (common in Type 2 Diabetes) causes cellular damage. Advanced Glycation End-products (AGEs): Studying the receptors for AGEs (RAGE) on smooth muscle cells and their role in inflammation.
Suitable for diabetic gastroenteropathy: studying how chronic hyperglycemia leads to motility disorders in the biliary tract. pharmacodynamics (pd): testing new drugs (prokinetic agents) designed to restore contraction in the diabetic gallbladder. mechanotransduction: studying how the physical stiffness of the diabetic environment affects cell signaling (yap/taz pathways). inflammation (lipotoxicity): investigating how high glucose combined with high lipids (common in type 2 diabetes) causes cellular damage. advanced glycation end-products (ages): studying the receptors for ages (rage) on smooth muscle cells and their role in inflammation. studies and research applications
Research Use Cases
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Technical Support & Documentation
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
